Developer docs
API playgroundTry for free, no card

Search company profiles

MicroConstants

Full company profile

uuid000tlij

Namestring
MicroConstants
Legal namestring
BioAgilytix Labs
Company typeenum
Private
Founded yearint
1998
Descriptiontext

MicroConstants is a privately-held, GLP-compliant Contract Research Organization founded in 1998 and headquartered in San Diego, California. The firm specializes in three tightly-related bioanalytical service areas: bioanalysis, drug metabolism, and pharmacokinetic (PK) analysis — the core laboratory disciplines required to characterize how drug candidates are absorbed, distributed, metabolized, and excreted, and to quantify drug and biomarker concentrations in biological matrices. Its positioning is as a focused, mid-sized specialized CRO (101-250 employees) rather than a diversified life sciences services platform, and its regulatory positioning rests on GLP compliance, a credential required for regulated bioanalytical work supporting FDA and other regulatory submissions.

The company is led by co-founders David F. Beyerlein and Gilbert Lam, with Lam serving as President and Chief Scientific Officer — a structure that keeps scientific leadership embedded in the executive team, consistent with the "scientist-to-scientist" engagement model common to bioanalytical CROs. Its business model is fee-for-service professional services revenue, with project-based engagements typical of the CRO segment (scope, timeline, and pricing driven by assay complexity, sample volume, and regulatory requirements). MicroConstants serves pharmaceutical and biotechnology sponsors requiring bioanalytical support for preclinical and clinical drug development programs. Public pricing is not disclosed, consistent with the customized, quote-based nature of bioanalytical study work.

The input data does not disclose revenue figures, customer names, geographic footprint beyond the San Diego headquarters, specific technology platforms, recent funding activity, or recent strategic transactions for MicroConstants. A substantial portion of the aggregated source material describes BioAgilytix (a separate, larger Durham-based bioanalytical CRO) and has been excluded from this assessment to avoid misattribution. As a result, MicroConstants' strategic positioning, technology stack, and recent momentum can only be described at a high level from the available firmographic data.

Short descriptiontext

MicroConstants is a privately-held, GLP-compliant contract research organization founded in 1998 in San Diego, California, providing bioanalysis, drug metabolism, and pharmacokinetic analysis services to pharmaceutical and biotechnology sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioanalytical CRO services, pharmacokinetic analysis, drug metabolism testing, GLP-compliant bioanalysis, contract research organization
Industry5 codes
PRIMARYHLAGADAA
Bioanalytical Testing (PK/ADA/NAb)
SECONDARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
NAICS code4 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Medical and Diagnostic Laboratories6215
  • Medical Laboratories621511
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
  • Services-Medical Laboratories8071
Product category
Contract Research Organization
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Bioanalytical Laboratory Services
TypeProfessional Services
Description

Fee-for-service laboratory testing model providing pharmacokinetic, immunogenicity, biomarker, and CMC analytical services to pharmaceutical and biotech clients. Revenue is generated through project-based contracts for assay development, validation, and sample analysis services performed in GxP-compliant environments.

bioagilytix.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details1 tier
1Project-based laboratory services
ModelOtherBilling cadenceMulti-year contract
Notes

Services are quoted on a per-project basis depending on assay complexity, sample volume, regulatory requirements, and timeline.

bioagilytix.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MicroConstants is a GLP-compliant Contract Research Organization providing bioanalysis, drug metabolism, and pharmacokinetic analysis services. The company supports pharmaceutical and biotechnology research programs with regulatory-compliant testing capabilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 800+ assays developed annually
+1 more record
Product overview1 text field

BioAgilytix is a global bioanalytical services company offering a unified platform of laboratory services for the pharmaceutical and biotechnology industries. The portfolio centers on four core service areas: Pharmacokinetics (PK) Services, Immunogenicity Services, Biomarker Testing, and CMC Analytical Services. Supporting these core offerings are capability modules including Method Transfer, Assay Development & Validation, Sample Analysis, Kit Production, and Consulting Services. The company also provides specialized techniques (Ligand Binding Assays, Cell-based Assays, Virology Assays, Molecular Assays, Mass Spectrometry) and operates advanced laboratory instrumentation platforms (MSD, PCR, Luminex, Biacore, LC/MS, Flow Cytometers). Operations are conducted across a global laboratory network spanning San Diego, Durham (headquarters), Boston, Hamburg (Europe headquarters), and Australia (via subsidiary 360biolabs), with partner labs in Beijing.

Product and service3 records
1Bioanalysis Services
CategoryBioanalytical Testing
2Drug Metabolism Services
CategoryDrug Metabolism Analysis
3Pharmacokinetic Analysis Services
CategoryPharmacokinetic Analysis
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

360biolabs is a BioAgilytix Company operating as their Australian subsidiary with laboratory locations in Brisbane and Melbourne. It operates under the BioAgilytix brand as an integrated part of their global laboratory network.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Frontage is a US-headquartered CRO with a bioanalytical, PK, and CMC analytical services business that directly overlaps BioAgilytix's core offerings for pharma and biotech sponsors, including biologics and small molecules. It is one of the closest direct competitors in bioanalytical testing scale and modality coverage.

TypeDirect peer
Description

Celerion specializes in early-phase clinical pharmacology, PK, and bioanalytical services for pharmaceutical and biotech clients, with a strong focus on first-in-human studies. It competes head-to-head with BioAgilytix for PK/PD and bioanalytical study work, particularly in early development.

TypeBroad incumbent
Description

Eurofins is a global testing services group with significant bioanalytical, pharmaceutical, and central laboratory capabilities serving pharma, biotech, and life-sciences clients. It competes with BioAgilytix in bioanalytical and biomarker testing but as part of a much broader testing portfolio.

TypeBroad incumbent
Description

Charles River is a large, diversified CRO offering preclinical, bioanalytical, and safety assessment services to pharma and biotech. Its bioanalytical and safety pharmacology units directly overlap BioAgilytix's PK, immunogenicity, and biomarker services but are bundled within a much wider CRO platform.

TypeBroad incumbent
Description

Labcorp, with Covance and the spun-out Fortrea, is a major clinical and bioanalytical services provider serving global pharma and biotech. It overlaps with BioAgilytix in central lab, bioanalytical, and biomarker services, typically as part of integrated clinical trial packages.

TypeBroad incumbent
Description

IQVIA is the largest global CRO and life-sciences services company, with central laboratory, bioanalytical, and clinical trial capabilities. It competes with BioAgilytix in bioanalytical and biomarker testing, typically offering these services bundled into enterprise clinical programs.

TypeBroad incumbent
Description

WuXi AppTec is a China-headquartered global CRO/CDMO with bioanalytical, DMPK, and biologics services that overlap BioAgilytix's offerings. It is a major global competitor, particularly attractive to sponsors seeking integrated discovery-to-clinical services at competitive cost.

TypeBroad incumbent
Description

SGS offers a global network of life-sciences testing laboratories including bioanalytical, bioequivalence, and central lab services for pharma and biotech. It competes with BioAgilytix in regulated bioanalytical testing as part of a broad testing, inspection, and certification portfolio.

TypeEmerging player
Description

Worldwide Clinical Trials is a mid-sized global CRO with bioanalytical, PK, and early-phase clinical capabilities serving pharma and biotech. It is a partial peer where BioAgilytix is a sub-contracted bioanalytical provider or where sponsors weigh standalone bioanalytical against bundled CRO offerings.

TypeEmerging player
Description

Pharmaron is a China-rooted, global CRO/CDMO offering DMPK, bioanalytical, and biologics services that overlap BioAgilytix's core menu. It is a meaningful emerging competitor in integrated discovery-through-clinical bioanalysis, especially for sponsors seeking Asia-Pacific capacity.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MicroConstants

Contract Research Organizationmicroconstants.com

MicroConstants is a privately-held, GLP-compliant contract research organization founded in 1998 in San Diego, California, providing bioanalysis, drug metabolism, and pharmacokinetic analysis services to pharmaceutical and biotechnology sponsors.

What MicroConstants does

MicroConstants is a privately-held, GLP-compliant Contract Research Organization founded in 1998 and headquartered in San Diego, California. The firm specializes in three tightly-related bioanalytical service areas: bioanalysis, drug metabolism, and pharmacokinetic (PK) analysis — the core laboratory disciplines required to characterize how drug candidates are absorbed, distributed, metabolized, and excreted, and to quantify drug and biomarker concentrations in biological matrices. Its positioning is as a focused, mid-sized specialized CRO (101-250 employees) rather than a diversified life sciences services platform, and its regulatory positioning rests on GLP compliance, a credential required for regulated bioanalytical work supporting FDA and other regulatory submissions.

The company is led by co-founders David F. Beyerlein and Gilbert Lam, with Lam serving as President and Chief Scientific Officer — a structure that keeps scientific leadership embedded in the executive team, consistent with the "scientist-to-scientist" engagement model common to bioanalytical CROs. Its business model is fee-for-service professional services revenue, with project-based engagements typical of the CRO segment (scope, timeline, and pricing driven by assay complexity, sample volume, and regulatory requirements). MicroConstants serves pharmaceutical and biotechnology sponsors requiring bioanalytical support for preclinical and clinical drug development programs. Public pricing is not disclosed, consistent with the customized, quote-based nature of bioanalytical study work.

The input data does not disclose revenue figures, customer names, geographic footprint beyond the San Diego headquarters, specific technology platforms, recent funding activity, or recent strategic transactions for MicroConstants. A substantial portion of the aggregated source material describes BioAgilytix (a separate, larger Durham-based bioanalytical CRO) and has been excluded from this assessment to avoid misattribution. As a result, MicroConstants' strategic positioning, technology stack, and recent momentum can only be described at a high level from the available firmographic data.

MicroConstants firmographics

Firmographics
Name
MicroConstants
Legal name
BioAgilytix Labs
Website
https://microconstants.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
101–250 employees
Short description
MicroConstants is a privately-held, GLP-compliant contract research organization founded in 1998 in San Diego, California, providing bioanalysis, drug metabolism, and pharmacokinetic analysis services to pharmaceutical and biotechnology sponsors.
Ownership category
akta.pro rank

MicroConstants industry classification

Industry
Product category
Contract Research Organization
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGADAA
Bioanalytical Testing (PK/ADA/NAb)
SECONDARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)

Keywords

  • Bioanalytical CRO services
  • Pharmacokinetic analysis
  • Drug metabolism testing
  • GLP-compliant bioanalysis
  • Contract research organization

Where MicroConstants is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices7 records

Markets served

MicroConstants business model

Business model
GTM type
B2B
Offering type
Services

Revenue model

  1. Bioanalytical Laboratory Services: Fee-for-service laboratory testing model providing pharmacokinetic, immunogenicity, biomarker, and CMC analytical services to pharmaceutical and biotech clients. Revenue is generated through project-based contracts for assay development, validation, and sample analysis services performed in GxP-compliant environments.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProject-based laboratory services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

MicroConstants product offering

Product offering

Core offering

MicroConstants is a GLP-compliant Contract Research Organization providing bioanalysis, drug metabolism, and pharmacokinetic analysis services. The company supports pharmaceutical and biotechnology research programs with regulatory-compliant testing capabilities.

Product overview

BioAgilytix is a global bioanalytical services company offering a unified platform of laboratory services for the pharmaceutical and biotechnology industries. The portfolio centers on four core service areas: Pharmacokinetics (PK) Services, Immunogenicity Services, Biomarker Testing, and CMC Analytical Services. Supporting these core offerings are capability modules including Method Transfer, Assay Development & Validation, Sample Analysis, Kit Production, and Consulting Services. The company also provides specialized techniques (Ligand Binding Assays, Cell-based Assays, Virology Assays, Molecular Assays, Mass Spectrometry) and operates advanced laboratory instrumentation platforms (MSD, PCR, Luminex, Biacore, LC/MS, Flow Cytometers). Operations are conducted across a global laboratory network spanning San Diego, Durham (headquarters), Boston, Hamburg (Europe headquarters), and Australia (via subsidiary 360biolabs), with partner labs in Beijing.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bioanalysis Services
  • Drug Metabolism Services
  • Pharmacokinetic Analysis Services

Quantifiable outcome

  • 800+ assays developed annually
  • +1 more outcomes

Companies that use MicroConstants

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles1 record

MicroConstants technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

MicroConstants partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • 360biolabscoreStrategic or Co-development Partner360biolabs is a BioAgilytix Company operating as their Australian subsidiary with laboratory locations in Brisbane and Melbourne. It operates under the BioAgilytix brand as an integrated part of their global laboratory network.

Scale indicators5 records

Recent moves3 records

Expansion highlights3 records

MicroConstants competitors and assessment

Company assessment

Direct peers

  • Frontage Laboratories: Frontage is a US-headquartered CRO with a bioanalytical, PK, and CMC analytical services business that directly overlaps BioAgilytix's core offerings for pharma and biotech sponsors, including biologics and small molecules. It is one of the closest direct competitors in bioanalytical testing scale and modality coverage.
  • Celerion: Celerion specializes in early-phase clinical pharmacology, PK, and bioanalytical services for pharmaceutical and biotech clients, with a strong focus on first-in-human studies. It competes head-to-head with BioAgilytix for PK/PD and bioanalytical study work, particularly in early development.

Broad incumbents

  • Eurofins Scientific: Eurofins is a global testing services group with significant bioanalytical, pharmaceutical, and central laboratory capabilities serving pharma, biotech, and life-sciences clients. It competes with BioAgilytix in bioanalytical and biomarker testing but as part of a much broader testing portfolio.
  • Charles River Laboratories: Charles River is a large, diversified CRO offering preclinical, bioanalytical, and safety assessment services to pharma and biotech. Its bioanalytical and safety pharmacology units directly overlap BioAgilytix's PK, immunogenicity, and biomarker services but are bundled within a much wider CRO platform.
  • Labcorp (incl. Covance/Fortrea): Labcorp, with Covance and the spun-out Fortrea, is a major clinical and bioanalytical services provider serving global pharma and biotech. It overlaps with BioAgilytix in central lab, bioanalytical, and biomarker services, typically as part of integrated clinical trial packages.
  • IQVIA: IQVIA is the largest global CRO and life-sciences services company, with central laboratory, bioanalytical, and clinical trial capabilities. It competes with BioAgilytix in bioanalytical and biomarker testing, typically offering these services bundled into enterprise clinical programs.
  • WuXi AppTec: WuXi AppTec is a China-headquartered global CRO/CDMO with bioanalytical, DMPK, and biologics services that overlap BioAgilytix's offerings. It is a major global competitor, particularly attractive to sponsors seeking integrated discovery-to-clinical services at competitive cost.
  • SGS Life Sciences: SGS offers a global network of life-sciences testing laboratories including bioanalytical, bioequivalence, and central lab services for pharma and biotech. It competes with BioAgilytix in regulated bioanalytical testing as part of a broad testing, inspection, and certification portfolio.

Emerging players

  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO with bioanalytical, PK, and early-phase clinical capabilities serving pharma and biotech. It is a partial peer where BioAgilytix is a sub-contracted bioanalytical provider or where sponsors weigh standalone bioanalytical against bundled CRO offerings.
  • Pharmaron: Pharmaron is a China-rooted, global CRO/CDMO offering DMPK, bioanalytical, and biologics services that overlap BioAgilytix's core menu. It is a meaningful emerging competitor in integrated discovery-through-clinical bioanalysis, especially for sponsors seeking Asia-Pacific capacity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

MicroConstants social profiles

Digital presence

MicroConstants financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MicroConstants leadership team

Management profile

Number of profiles

Profiles2 records

MicroConstants subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

MicroConstants funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MicroConstants M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MicroConstants

What does MicroConstants do?

MicroConstants is a GLP-compliant Contract Research Organization providing bioanalysis, drug metabolism, and pharmacokinetic analysis services. The company supports pharmaceutical and biotechnology research programs with regulatory-compliant testing capabilities.

Is MicroConstants a public or private company?

MicroConstants is a private company. It is classified as unknown and is currently operating.

When was MicroConstants founded?

MicroConstants was founded in 1998. It employs 101 to 250 people.

Where is MicroConstants based?

MicroConstants is headquartered in San Diego, United States, in the North America region.

How does MicroConstants make money?

One revenue line is on record: bioanalytical Laboratory Services.

Who are MicroConstants's main competitors?

Direct peers on record are Frontage Laboratories and Celerion. Broad incumbents are Eurofins Scientific, Charles River Laboratories, Labcorp (incl. Covance/Fortrea), IQVIA, WuXi AppTec and SGS Life Sciences. Emerging players are Worldwide Clinical Trials and Pharmaron.

Does MicroConstants have an API?

No public API is recorded for MicroConstants.

What industry is MicroConstants in?

MicroConstants's product category is Contract Research Organization. Its primary akta.pro industry code is HLAGADAA, Bioanalytical Testing (PK/ADA/NAb), with a secondary code of HLAGADAH, Cell-Based & Potency Assays (Bioassays). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
socaltech.comMicroConstants Acquired By BioAgilytixMicroConstants, a bioanalytical testing services provider based in San Diego, has agreed to be acquired by BioAgilytix Labs, a contract research organization focused on large molecule drug development. Post-acquisition, MicroConstants will operate under the name BioAgilytix San Diego, while its China division remains independent. The financial terms of the acquisition have not been disclosed.PR NewswireMicroConstants rejoint la famille BioAgilytixBioAgilytix Labs, LLC announced on August 19, 2021 that it signed a definitive agreement to acquire MicroConstants, Inc., adding the GLP-compliant clinical and preclinical contract research organization to its family of companies. MicroConstants, which will be rebranded as BioAgilytix San Diego, provides bioanalytical services using LC/MS/MS, HPLC, immunoassays, and qPCR techniques and has supported over 290 biotech and pharmaceutical companies since 1998. The acquisition is expected to create scientific and performance synergies while expanding BioAgilytix's presence on the US West Coast and better serving the growing biotech community.PR NewswireMicroConstants to Join BioAgilytix FamilyBioAgilytix signed a definitive agreement to acquire MicroConstants, adding it as BioAgilytix San Diego. MicroConstants, a GLP-compliant bioanalysis CRO, has supported 290+ clients since 1998. The acquisition aims to create synergies and better serve the West Coast biotech community.BioAgilytixMicroConstants to Join BioAgilytix FamilyBioAgilytix Labs, LLC signed a definitive agreement to acquire MicroConstants, a bioanalytical services provider based in San Diego. The transaction adds LC/MS capabilities and expands BioAgilytix's team of scientists to better serve the biotechnology community on the West Coast. MicroConstants China remains a separate business entity and is not included in this acquisition.PR NewswireMicroConstants wird Mitglied der BioAgilytix FamilieBioAgilytix Labs, a leading global contract research laboratory specializing in large molecule bioanalysis, announced on August 19, 2021, the signing of a definitive agreement to acquire MicroConstants, a GLP-compliant clinical and preclinical CRO focused on regulated bioanalysis and pharmacokinetic services. The acquisition will integrate MicroConstants, which will be renamed BioAgilytix San Diego, expanding the company's LC/MS/MS capabilities and strengthening its presence in the West Coast biotechnology community. MicroConstants China will remain a separate business unit and is not included in this transaction.PR NewswireMicroConstants se une a la familia de BioAgilytixBioAgilytix Labs, a leading contract research laboratory focused on large molecule drug development, announced on August 18, 2021 the signing of a definitive agreement to acquire MicroConstants, a GLP-compliant clinical and preclinical CRO based in San Diego. The highly complementary transaction adds LC/MS/MS capabilities and expands BioAgilytix's team of experienced scientists while strengthening its ability to support bioanalytical services across major therapies in development. MicroConstants, which has supported over 290 biotech and pharmaceutical companies since 1998 and completed more than 8,200 projects, will be rebranded as BioAgilytix San Diego, with MicroConstants China remaining an independent commercial entity outside this transaction.